1. Academic Validation
  2. Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis

Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis

  • Sci Immunol. 2018 Aug 24;3(26):eaat2738. doi: 10.1126/sciimmunol.aat2738.
Joseph K Rathkey 1 Junjie Zhao 2 Zhonghua Liu 1 Yinghua Chen 3 Jie Yang 1 3 Hannah C Kondolf 1 Bryan L Benson 1 Steven M Chirieleison 1 Alex Y Huang 1 4 George R Dubyak 3 Tsan S Xiao 1 Xiaoxia Li 2 Derek W Abbott 5
Affiliations

Affiliations

  • 1 Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
  • 2 Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
  • 3 Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
  • 4 Division of Pediatric Hematology-Oncology, Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
  • 5 Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA. [email protected].
Abstract

Dysregulation of inflammatory cell death is a key driver of many inflammatory diseases. Pyroptosis, a highly inflammatory form of cell death, uses intracellularly generated pores to disrupt electrolyte homeostasis and execute cell death. Gasdermin D, the pore-forming effector protein of Pyroptosis, coordinates membrane lysis and the release of highly inflammatory molecules, such as interleukin-1β, which potentiate the overactivation of the innate immune response. However, to date, there is no pharmacologic mechanism to disrupt Pyroptosis. Here, we identify necrosulfonamide as a direct chemical inhibitor of gasdermin D, the pyroptotic pore-forming protein, which binds directly to gasdermin D to inhibit Pyroptosis. Pharmacologic inhibition of pyroptotic cell death by necrosulfonamide is efficacious in sepsis models and suggests that gasdermin D inhibitors may be efficacious clinically in inflammatory diseases.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-13638
    99.67%, IAP Inhibitor
    IAP